{"id":2138237,"date":"2025-04-30T07:52:04","date_gmt":"2025-04-30T06:52:04","guid":{"rendered":"https:\/\/www.thebusinessdesk.com\/yorkshire\/?p=2138237"},"modified":"2025-04-30T08:12:20","modified_gmt":"2025-04-30T07:12:20","slug":"life-sciences-company-signs-university-vaccine-deal","status":"publish","type":"post","link":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal","title":{"rendered":"Life sciences company signs university vaccine deal"},"content":{"rendered":"<p style=\"font-weight: 400\">Life sciences company Aptamer Group has signed a licensing agreement with the University of Glasgow for exclusive rights to its synthetic binders to develop swine flu vaccines.<\/p>\n<p style=\"font-weight: 400\">Under the agreement, the university will use Aptamer\u2019s panel of optimer binders as vaccine adjuvants with commercialisation anticipated within the next 12 months.<\/p>\n<p style=\"font-weight: 400\">York-based Aptamer will receive a 10% royalty on all future revenues from any vaccines incorporating the licensed optimers, creating a scalable and global revenue stream.<\/p>\n<p style=\"font-weight: 400\">This partnership provides Aptamer access to the $1.75bn global swine vaccine market, an industry experiencing sustained demand for improved animal health solutions.<\/p>\n<p style=\"font-weight: 400\">Dr Arron Tolley, CEO of Aptamer, said: \u201cThis licensing deal represents an important milestone in the commercialisation of our optimer technology. It demonstrates our ability to deliver high-value solutions across diverse sectors and builds on our strategic focus of monetising optimer-based assets beyond our core focus in human health. With growing demand for advanced animal health solutions, this partnership creates a global pathway to recurring revenues while validating the robustness and versatility of our Optimer platform.<\/p>\n<p style=\"font-weight: 400\">\u00a0\u201cThis agreement reinforces Aptamer&#8217;s broader commercial strategy of leveraging its proprietary platform across multiple verticals, including targeted drug delivery for human therapeutics, diagnostics, personal care, research reagents, and now veterinary vaccines, to generate long-term shareholder value.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>University of Glasgow has exclusive rights to Aptamer&#8217;s synthetic binders to develop swine flu vaccines.<\/p>\n","protected":false},"author":271992,"featured_media":2138238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"coauthors":[137100],"class_list":["post-2138237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-featured-story","tag-yorkshire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Life sciences company signs university vaccine deal | TheBusinessDesk.com<\/title>\n<meta name=\"description\" content=\"University of Glasgow has exclusive rights to Aptamer&#039;s synthetic binders to develop swine flu vaccines.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Life sciences company signs university vaccine deal | TheBusinessDesk.com\" \/>\n<meta property=\"og:description\" content=\"University of Glasgow has exclusive rights to Aptamer&#039;s synthetic binders to develop swine flu vaccines.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal\" \/>\n<meta property=\"og:site_name\" content=\"Yorkshire\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-30T06:52:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-30T07:12:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sheryl Moore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sheryl Moore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal\",\"url\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal\",\"name\":\"Life sciences company signs university vaccine deal | TheBusinessDesk.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg\",\"datePublished\":\"2025-04-30T06:52:04+00:00\",\"dateModified\":\"2025-04-30T07:12:20+00:00\",\"author\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845\"},\"description\":\"University of Glasgow has exclusive rights to Aptamer's synthetic binders to develop swine flu vaccines.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#primaryimage\",\"url\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg\",\"contentUrl\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life sciences company signs university vaccine deal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website\",\"url\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/\",\"name\":\"Yorkshire\",\"description\":\"Regional business news for Yorkshire\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845\",\"name\":\"Sheryl Moore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/image\/30080a04dad1693c9d397756bce5f202\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g\",\"caption\":\"Sheryl Moore\"},\"url\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/author\/sherylmoore\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Life sciences company signs university vaccine deal | TheBusinessDesk.com","description":"University of Glasgow has exclusive rights to Aptamer's synthetic binders to develop swine flu vaccines.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal","og_locale":"en_GB","og_type":"article","og_title":"Life sciences company signs university vaccine deal | TheBusinessDesk.com","og_description":"University of Glasgow has exclusive rights to Aptamer's synthetic binders to develop swine flu vaccines.","og_url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal","og_site_name":"Yorkshire","article_published_time":"2025-04-30T06:52:04+00:00","article_modified_time":"2025-04-30T07:12:20+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg","type":"image\/jpeg"}],"author":"Sheryl Moore","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sheryl Moore","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal","url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal","name":"Life sciences company signs university vaccine deal | TheBusinessDesk.com","isPartOf":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#primaryimage"},"image":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#primaryimage"},"thumbnailUrl":"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg","datePublished":"2025-04-30T06:52:04+00:00","dateModified":"2025-04-30T07:12:20+00:00","author":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845"},"description":"University of Glasgow has exclusive rights to Aptamer's synthetic binders to develop swine flu vaccines.","breadcrumb":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#primaryimage","url":"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg","contentUrl":"https:\/\/www.thebusinessdesk.com\/_files\/images\/apr_25\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-3-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2138237-life-sciences-company-signs-university-vaccine-deal#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thebusinessdesk.com\/yorkshire\/"},{"@type":"ListItem","position":2,"name":"Life sciences company signs university vaccine deal"}]},{"@type":"WebSite","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website","url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/","name":"Yorkshire","description":"Regional business news for Yorkshire","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thebusinessdesk.com\/yorkshire\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845","name":"Sheryl Moore","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/image\/30080a04dad1693c9d397756bce5f202","url":"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g","caption":"Sheryl Moore"},"url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/author\/sherylmoore"}]}},"_links":{"self":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts\/2138237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/users\/271992"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/comments?post=2138237"}],"version-history":[{"count":2,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts\/2138237\/revisions"}],"predecessor-version":[{"id":2138246,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts\/2138237\/revisions\/2138246"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/media\/2138238"}],"wp:attachment":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/media?parent=2138237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/categories?post=2138237"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/coauthors?post=2138237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}